Title : Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer.

Pub. Date : 2004 Jan 12

PMID : 14710203






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer. Paclitaxel erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 Synergism between anti-HER2 monoclonal antibody (trastuzumab) and paclitaxel has been shown in vitro and in vivo. Paclitaxel erb-b2 receptor tyrosine kinase 2 Homo sapiens
3 These results confirm that weekly administration of trastuzumab and paclitaxel is active in anthracycline- and taxane-pretreated metastatic breast cancer patients HER2-overexpressing. Paclitaxel erb-b2 receptor tyrosine kinase 2 Homo sapiens